GARDP as Sponsor, is collaborating with 2 partners for the conduct of the following clinical trial:
An open label randomized controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of neonatal sepsis with a run-in confirmatory pharmacokinetic phase (NeoSep1).
This clinical trial is divided in 2 parts. The first part is now completed.
This RFP is for the second part that will be conducted in about 16 sites spread between Asia, Middle East and Africa.

If you are interested to receive complete documentation of this RFP, please send a request to: RFP_Procurement@gardp.org.$

Due/closing date: 26 March 2024